Association of hydrophilic versus lipophilic angiotensin-converting enzyme inhibitor use on pneumonia-related mortality

American Journal of the Medical Sciences

Volumn 336, Issue 6, 2008, Pages 462-466

  Mortensen, Eric M ^a,b   Restrepo, Marcos I ^a,b   Copeland, Laurel A ^a,b   Pugh, Jacqueline A ^b   Anzueto, Antonio ^b  

^a VERDICT   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Angiotensin converting enzyme; Mortality; Pneumonia

Indexed keywords

ANTIINFECTIVE AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; QUINAPRIL; RAMIPRIL;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HOSPITALIZATION; HUMAN; HYDROPHILICITY; LIPOPHILICITY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; RETROSPECTIVE STUDY; CHEMISTRY; MIDDLE AGED; PNEUMONIA; REGRESSION ANALYSIS; SURVIVAL RATE;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 59049087675     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31817149ed     Document Type: Article

References (27)

1. Hoyert DL, Heron MP, Murphy SL, et al. Deaths: final data for 2003. Natl Vital Stat Rep 2006;54:1-120.
2. Gilbert K, Fine MJ. Assessing prognosis and predicting patient outcomes in community-acquired pneumonia. Semin Respir Infect 1994;9:140-52.
3. Arai T, Sekizawa K, Ohrui T, et al. ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology 2005;64:573-4.
4. Ohkubo T, Chapman N, Neal B, et al. Effects of an angio-tensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med 2004;169:1041-5.
5. Okaishi K, Morimoto S, Fukuo K, et al. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients. Am J Hypertens 1999;12(8 pt 1):778-83.
6. van de Garde EM, Souverein PC, van den Bosch JM, et al. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. Eur Respir J 2006;27:1217-22.
7. Etminan M, Zhang B, Fitzgerald M, et al. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study. Pharmacotherapy 2006;26:479-82.
8. Liappis AP, Kan VL, Rochester CG, et al. The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 2001;33:1352-7.
9. Mortensen EM, Restrepo MI, Anzueto A, et al. The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia. BMC Pulm Med 2005;5:12.
10. Moskowitz DW, Johnson FE. The central role of angioten-sin I-converting enzyme in vertebrate pathophysiology. Curr Top Med Chem 2004;4:1433-54.
11. Wei L, Clauser E, Alhenc-Gelas F, et al. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J Biol Chem 1992;267:13398-405.
12. Ondetti MA. Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity. Circulation 1988;77(6 pt 2):I74-I78.
13. Mortensen EM, Restrepo MI, Anzueto A, et al. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respir Res 2005; 6:82.
14. Niederman MS, Mandell LA, AnzuetoA, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-54.
15. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000;31:347-82.
16. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
17. Stone RA, Obrosky DS, Singer DE, et al. Propensity score adjustment for pretreatment differences between hospitalized and ambulatory patients with community-acquired pneumonia. Pneumonia Patient Outcomes Research Team (PORT) Investigators. Med Care 1995; 33(suppl 4):AS56-AS66.
18. Mortensen EM, Restrepo M, Anzueto A, et al. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med 2004;117:726-31.
19. Dagenais NJ, Jamali F. Protective effects of angiotensin II interruption: evidence for antiinflammatory actions. Phar-macotherapy 2005;25:1213-29.
20. Marshall RP. The pulmonary renin-angiotensin system. Curr Pharm Des 2003;9:715-22.
21. Gullestad L, Aukrust P, Ueland T, et al. Effect of high-versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol 1999;34:2061-7.
22. Sheth T, Parker T, Block A, et al. Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure. Am J Cardiol 2002;90:496-500.
23. Peeters AC, Netea MG, Kullberg BJ, et al. The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology 1998;94:376-9.
24. Mancini GB, Khalil N. Angiotensin II type 1 receptor blocker inhibits pulmonary injury. Clin Invest Med 2005;28: 118-26.
25. Mancini GB, Etminan M, Zhang B, et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006;47:2554-60.
26. Marshall RP, Webb S, Bellingan GJ, et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;166: 646-50.
27. Jerng JS, Yu CJ, Wang HC, et al. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit Care Med 2006;34: 1001-6.